EUCTR2006-005797-44-FR进行中（未招募）1 期
Efficacy and safety of the fixed oral low-dose perindopril arginine 3.5 mg/amlodipine 2.5 mg combination compared with each component (perindopril arginine 3.5 mg and amlodipine 2.5 mg) and with perindopril arginine 5 mg and amlodipine 5 mg.Randomized, double-blind, placebo-controlled study over 8 weeks in hypertensive patients.
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 1,500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Men or women,
- •- 18 to 80 years old,
- •- Essential uncomplicated mild to moderate hypertensive patients
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- pregnancy,
- •- obesity,
- •- perindopril resistant hypertension,
- •- amlodipine resistant hypertension,
- •- secondary hypertension.
研究者
相似试验
进行中（未招募）
1 期
Efficacy and safety of the fixed oral low-dose perindopril arginine 3.5 mg/amlodipine 2.5 mg combination compared with each component (perindopril arginine 3.5 mg and amlodipine 2.5 mg) and with perindopril arginine 5 mg and amlodipine 5 mg.Randomized, double-blind, placebo-controlled study over 8 weeks in hypertensive patients.EUCTR2006-005797-44-HUInstitut de Recherches Internationales Servier1,500
进行中（未招募）
不适用
Efficacy and safety of the fixed oral low-dose perindopril arginine 3.5 mg/amlodipine 2.5 mg combination compared with each component (perindopril arginine 3.5 mg and amlodipine 2.5 mg) and with perindopril arginine 5 mg and amlodipine 5 mg.Randomized, double-blind, placebo-controlled study over 8 weeks in hypertensive patients.Essential arterial hypertensionMedDRA version: 8.1Level: LLTClassification code 10020775Term: Hypertension arterialEUCTR2006-005797-44-LTInstitut de Recherches Internationales Servier1,500
进行中（未招募）
不适用
Efficacy and safety of the fixed oral low-dose perindopril arginine 3.5 mg/amlodipine 2.5 mg combination compared with each component (perindopril arginine 3.5 mg and amlodipine 2.5 mg) and with perindopril arginine 5 mg and amlodipine 5 mg.Randomized, double-blind, placebo-controlled study over 8 weeks in hypertensive patients.EUCTR2006-005797-44-LVInstitut de Recherches Internationales Servier1,500
招募中
2 期
Effect of oral Atrovastatin on inflammatory factors in patients with traumatic brain injuryIRCT20191016045127N1Ahvaz University of Medical Sciences60
招募中
Unknown
Efficacy and Safety of single oral dose method of the Picoprep in colonoscopyJPRN-jRCTs051220195Kodama Yuzo145